Trolamine

Trolamine

SCHEMBL2051249

OCCN(CCO)CCO.[Mg]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALOX15 P16050 1/20 0.39
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trolamine SCHEMBL15845959 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL4748243 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL1146 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL434089 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
SCHEMBL23528233 0.91 MAPT (0.46) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL5862137 0.91 MAPT (0.44) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL9716114 0.91 TSHR (0.46) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL565435 0.91 MAPT (0.44) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL5934922 0.91 MAPT (0.44) MAPTKDM4ESMN1; SMN2ALOX15HPGD
SCHEMBL2157617 0.91 MAPT (0.46) MAPTKDM4ESMN1; SMN2ALOX15HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642975-B1 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME SHOWA DENKO KK (JP) 2016-08-24 EP disclosed
US-9180079-B2 Skin external preparation and method of producing same SHOWA DENKO K.K. (JP) 2015-11-10 US disclosed
EP-2514405-B1 Silicone Microemulsion Composition SHINETSU CHEMICAL CO (JP) 2014-01-22 EP disclosed
US-20130287718-A1 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME SHOWA DENKO K.K. (JP) 2013-10-31 US disclosed
EP-2642975-A2 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME Showa Denko K.K. (JP) 2013-10-02 EP disclosed
EP-1541633-B1 AQUEOUS SUSPENSION OF CROSSLINKED SILICONE PARTICLES, AQUEOUS EMULSION OF OIL CONTAINING CROSSLINKED SILICONE PARTICLES, AND COSMETIC INGREDIENTS DOW CORNING TORAY CO LTD (JP) 2013-01-16 EP disclosed
US-8329816-B2 Silicone microemulsion composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
WO-2012153825-A2 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME SHOWA DENKO K.K. (JP) 2012-11-15 WO disclosed
US-20120270985-A1 SILICONE MICROEMULSION COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-10-25 US disclosed
EP-2514405-A1 Silicone Microemulsion Composition Shin-Etsu Chemical Co., Ltd. (JP) 2012-10-24 EP disclosed
CN-101378747-A Whitening dermatological preparations SHOWA DENKO KK (JP) 2009-03-04 CN disclosed
EP-1858982-B1 SILICONE EMULSION, METHOD OF PREPARING SAME, AND COSMETIC INGREDIENT DOW CORNING (US) 2008-08-27 EP disclosed
US-20080182833-A1 Silicone Emulsion, Method of Preparing Same, and Cosmetic Ingredient DOW CORNING CORPORATION 2008-07-31 US disclosed
EP-1858982-A1 SILICONE EMULSION, METHOD OF PREPARING SAME, AND COSMETIC INGREDIENT Dow Corning Corporation (US) 2007-11-28 EP disclosed
US-7300648-B2 Polyorganosiloxane emulsion composition and a cosmetic material made therefrom DOWECORNING TORAY SILICONE, CO., LTD. (JP) 2007-11-27 US disclosed
WO-2006102010-A1 SILICONE EMULSION, METHOD OF PREPARING SAME, AND COSMETIC INGREDIENT DOW CORNING CORPORATION (US) 2006-09-28 WO disclosed
US-20060127338-A1 Aqueous suspensions of cross-linked silicone particles, aqueous emulsions of oil containing cross-linked silicone particles, and cosmetic raw material DOW CORNING TORAY COMPANY, LTD. (JP) 2006-06-15 US disclosed
EP-1541633-A1 AQUEOUS SUSPENSION OF CROSSLINKED SILICONE PARTICLES, AQUEOUS EMULSION OF OIL CONTAINING CROSSLINKED SILICONE PARTICLES, AND COSMETIC INGREDIENTS Dow Corning Toray Silicone Company, Ltd. (JP) 2005-06-15 EP disclosed
US-20040138373-A1 Polyorganosiloxane emulsion composition and a cosmetic material made therefrom DOW TORAY CO., LTD. (JP) 2004-07-15 US disclosed
US-4071487-A Anti-settling agents for pigmented aqueous lacquer and process for the manufacture of said agents HENKEL KGAA (DT) 1978-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060127338-A1 Aqueous suspensions of cross-linked silicone particles, aqueous emulsions of oil containing cross-linked silicone particles, and cosmetic raw material H1-0, CD44, H1-2 MAPT 69/4885KDM4E 3966/4885SMN1; SMN2 182/4885
US-20130287718-A1 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME RBP4, RBP1, PROC MAPT 4355/4885KDM4E 4014/4885SMN1; SMN2 2725/4885
US-20080182833-A1 Silicone Emulsion, Method of Preparing Same, and Cosmetic Ingredient SQLE, CUTA, SMOX MAPT 3009/4885KDM4E 4047/4885SMN1; SMN2 2819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.